Research ExplorerJournalsPROSTATE CANCER P D Publications

PROSTATE CANCER P D - Prostate cancer and prostatic diseases

1 - 15 out of 15Page size: 50

Publications

  1. 2023

  2. Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

    Wenzel, M., Nocera, L., Collà Ruvolo, C., Würnschimmel, C., Tian, Z., Shariat, S. F., Saad, F., Tilki, D., Graefen, M., Kluth, L. A., Briganti, A., Mandel, P., Montorsi, F., Chun, F. K. H. & Karakiewicz, P. I., 12.2023, In: PROSTATE CANCER P D. 26, 4, p. 807-808 2 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  3. 2022

  4. Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis

    Sari Motlagh, R., Yanagisawa, T., Kawada, T., Laukhtina, E., Rajwa, P., Aydh, A., König, F., Pallauf, M., Huebner, N. A., Baltzer, P. A., Karakiewicz, P. I., Heidenreich, A. & Shariat, S. F., 02.2022, In: PROSTATE CANCER P D. 25, 2, p. 187-198 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  5. Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

    Wenzel, M., Nocera, L., Collà Ruvolo, C., Würnschimmel, C., Tian, Z., Shariat, S. F., Saad, F., Tilki, D., Graefen, M., Kluth, L. A., Briganti, A., Mandel, P., Montorsi, F., Chun, F. K. H. & Karakiewicz, P. I., 02.2022, In: PROSTATE CANCER P D. 25, 2, p. 139-148 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  6. 2021

  7. KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy

    Lunger, L., Retz, M., Bandur, M., Souchay, M., Vitzthum, E., Jäger, M., Weirich, G., Schuster, T., Autenrieth, M., Kübler, H., Maurer, T., Thalgott, M., Herkommer, K., Koll, F., Gschwend, J. E., Nawroth, R. & Heck, M. M., 06.2021, In: PROSTATE CANCER P D. 24, 2, p. 362-369 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer

    Preisser, F., Gandaglia, G., Arad, F., Karakiewicz, P. I., Bandini, M., Pompe, R. S., Montorsi, F., Graefen, M., Huland, H., Briganti, A. & Tilki, D., 03.2021, In: PROSTATE CANCER P D. 24, 1, p. 193-201 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study

    Stolzenbach, L. F., Deuker, M., Collà-Ruvolo, C., Nocera, L., Mansour, M., Tian, Z., Tilki, D., Steuber, T., Briganti, A., Saad, F., Chun, F. K. H., Graefen, M. & Karakiewicz, P. I., 03.2021, In: PROSTATE CANCER P D. 24, 1, p. 253-260 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2020

  11. Contemporary national trends in prostate cancer risk profile at diagnosis

    Fletcher, S. A., von Landenberg, N., Cole, A. P., Gild, P., Choueiri, T. K., Lipsitz, S. R., Trinh, Q-D. & Kibel, A. S., 03.2020, In: PROSTATE CANCER P D. 23, 1, p. 81-87 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 2018

  13. The use of PET/CT in prostate cancer

    Li, R., Ravizzini, G. C., Gorin, M. A., Maurer, T., Eiber, M., Cooperberg, M. R., Alemozzaffar, M., Tollefson, M. K., Delacroix, S. E. & Chapin, B. F., 04.2018, In: PROSTATE CANCER P D. 21, 1, p. 4-21 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  14. Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study

    Pompe, R. S., Smith, A., Bandini, M., Marchioni, M., Martel, T., Preisser, F., Leyh-Bannurah, S-R., Schiffmann, J., Saad, F., Huland, H., Graefen, M., Shariat, S. F., Tilki, D. & Karakiewicz, P. I., 04.2018, In: PROSTATE CANCER P D. 21, 1, p. 71-77 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2017

  16. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer

    Tosco, L., Laenen, A., Briganti, A., Gontero, P., Karnes, R. J., Albersen, M., Bastian, P. J., Chlosta, P., Claessens, F., Chun, F. K., Everaerts, W., Gratzke, C., Graefen, M., Kneitz, B., Marchioro, G., Salas, R. S., Tombal, B., Van den Broeck, T., Moris, L., Battaglia, A., van der Poel, H., Walz, J., Bossi, A., De Meerleer, G., Haustermans, K., Van Poppel, H., Spahn, M., Joniau, S. & European Multictr Prostate Canc Cl , 12.2017, In: PROSTATE CANCER P D. 20, 4, p. 407-412 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2016

  18. The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy

    Sevcenco, S., Mathieu, R., Baltzer, P., Klatte, T., Fajkovic, H., Seitz, C., Karakiewicz, P. I., Rouprêt, M., Rink, M., Kluth, L., Trinh, Q-D., Loidl, W., Briganti, A., Scherr, D. S. & Shariat, S. F., 06.2016, In: PROSTATE CANCER P D. 19, 2, p. 163-7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2013

  20. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy

    Rieken, M., Kluth, L. A., Xylinas, E., Seitz, C., Fajkovic, H., Karakiewicz, P. I., Lotan, Y., Briganti, A., Loidl, W., Faison, T., Crivelli, J. J., Scherr, D. S., Bachmann, A., Tewari, A. K., Kautzky-Willer, A., Pummer, K. & Shariat, S. F., 01.12.2013, In: PROSTATE CANCER P D. 16, 4, p. 367-71 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy

    Tsourlakis, M. C., Delmo Walter, E. M., Quaas, A., Graefen, M., Huland, H., Simon, R., Sauter, G., Steurer, S., Schlomm, T. & Minner, S., 01.06.2013, In: PROSTATE CANCER P D. 16, 2, p. 159-64 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2011

  23. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.

    Hellwinkel, O., Asong, LE., Rogmann, J-P. J., Sültmann, H., Wagner, C., Schlomm, T. & Eichelberg, C., 2011, In: PROSTATE CANCER P D. 14, 1, p. 38-45 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2000

  25. Ratio free/total PSA (%f-PSA) in men with total PSA 0.5-3 ng/ml: improvement for prostate cancer detection?

    Hammerer, P., Graefen, M., Henke, R. P., Haese, A., Huland, E. & Huland, H., 2000, In: PROSTATE CANCER P D. 3, 1, p. 19 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review